跳至主要内容
临床试验/NCT05971043
NCT05971043尚未招募不适用

Skin Disorders in Patients Using Methamphetamine

Assiut University0 个研究点目标入组 500 人开始时间: 2023年8月3日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
主要终点
skin disorders in patients using methamphetamine

研究概览

简要总结

  1. To detect the skin diseases in patients using methamphetamine

详细描述

Methamphetamine is a stimulant drug that associated with a broad spectrum of health conditions, include addiction, mental health disorders, and overdose. The Drug Enforcement Agency (DEA) classifies it as a Schedule II drug. This means that the drug has a high potential for misuse. The drug is also called crystal meth, ice, and blue.

Methamphetamine use has increased in Egypt especially in upper Egypt. Literature on cutaneous manifestations among methamphetamine users is limited, although cellulitis, delusion of parasitosis (DOP), hyperhidrosis, formication and prurigo nodularis (PN) have been attributed to methamphetamine users. While the relationship between skin lesions and substance use in not fully defined, there is some evidence that points to the development of these itchy, red lesion also known as meth sore after meth use. Meth sores often look like small round red patches on your skin, they can often be confused with acne when they appear on the face or a rash when they appear on other parts of the body.

Meth sores form as a result of heavy meth misuse. other signs of meth abuse at the stage where sores likely to develop include:

  • Weight loss
  • Paranoia
  • Hallucinations
  • Aggressive behavior
  • Being easily distracted
  • Tooth and gum decay
  • Changes in brain structure

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
14 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients using methamphetamine

排除标准

  • Pregnant and lactating patients.
  • Patients with chronic diseases

结局指标

主要结局

skin disorders in patients using methamphetamine

时间窗: baseline

questionnaire-based study To detect the skin diseases and manifestation appears in patients using methamphetamine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asmaa mohamed hafez

principal investigator Dr asmaa mohamed hafez

Assiut University

相似试验